Elon's Greatest Invention... Hidden in South Memphis?

In South Memphis, I uncovered what could be Elon Musk's biggest invention yet. It's so secretive, rivals are flying drones to spy on it. If you're serious about investing in AI, now's the time to see what's really going on inside those walls.

APVO
Aptevo Therapeutics Inc
NASDAQ
2.98
Open 3.05 Prev Close 3.03
High 3.05 Low 2.93
Volume 143,300 Volume (Avg) 2,392
52 Week High 405.52 52 Week Low 2.81
Market Cap 9.6M PE Ratio

Shares Stats

Shares Outstanding3,220,000
Shares Float2,970,000
Shares Short160,000
Insider Holdings995%
Institution Holdings0.43%

About Aptevo Therapeutics Inc

Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells. Its lead clinical blood cancer candidate is mipletamig that is in Phase 1b/2 clinical trial for the treatment of acute myelogenous leukemia. The company also develops ALG.APV-527, a novel investigational bispecific ADAPTIR candidate that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer, head and neck, colorectal, pancreatic, breast, and other solid tumors; APVO603, a preclinical dual agonist bispecific ADAPTIR candidate to treat multiple solid tumors; APVO442, a preclinical bispecific candidate based on the ADAPTIR-FLEX platform technology for the treatment of multiple solid tumors; and APVO711, a preclinical dual mechanism bispecific ADAPTIR candidate to treat prostate cancer. It has a collaboration and option agreement with Alligator Bioscience AB to develop ALG.APV-527. Aptevo Therapeutics Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

General

NameAptevo Therapeutics Inc
TickerAPVO
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees37

Highlights

Analyst Target420.00
Market Cap9,600,000
EBITDA-23,792,000

Financials

Curr Year EPS Estimate-316.80
Next Quarter EPS Estimate-4.16
Return on Assets-1.16
Return on Equity-10.24
Earnings Per Share-325.05
Gross Profit171,000
Quarterly Revenue Growth-1

Valuation

Forward PE3.94
Price/Sales (Trailing 12 Mt.)1.61
Price/Book (Most Recent Quarter)0.37

Earnings

Most Popular

House sends bill regulating stablecoins, a type of cryptocurrency, to Trump

WASHINGTON (AP) — The House has passed two bills intended to boost the legitimacy of the cryptocurrency industry with new regulations as President has pushed to make the U.S. the “ of the world.”

Trump keeps saying the GOP mega bill will eliminate taxes on Social Security. It does not

WASHINGTON (AP) — President keeps saying that Republicans' mega legislation will eliminate taxes on federal benefits.

Gold Just Hit Another Record. This Junior Could Be Next. - Ad

This copper junior was the smallest company invited to a top global mining conference. With nearly 1B pounds CuEq and 50,000m of funded drilling, this story won't stay quiet for long.

After Diddy's conviction, here's where his business ventures stand

LOS ANGELES (AP) — Sean “Diddy” Combs has been in his federal sex trafficking trial, but that doesn't mean the once-celebrated music mogul will see his business empire restored.

Do as I say, not as I do: On my failings as an investor

If a knowledgeable observer trained his or her sights on my choices, what are the trouble spots they would identify? Here are some of the biggies.

Robotics Meets Public Safety Innovation - Ad

Advanced security robots, real-world impact, and a valuation gap too big to ignore. This robotics stock is one to watch.

Embed-chart-July Fourth-Pool Party Prices, ADVISORY

JULY FOURTH-POOL PARTY PRICES — chart. A market research company’s preliminary data shows that getting all the gear needed to host a pool party costs less than it has in years. This chart is current as of 07, 03, 2025 and will not update. Source: Numerator

Greenland has a message for the rest of the world: Come visit

NUUK, Greenland (AP) — has a message for the rest of the world: We’re waiting for you.

From Ferrari to Bombardier - This Tiny Company Is Everywhere - Ad

A $150M disruptor is transforming glass into real-time displays and vision systems. Already embedded in global OEMs and Tier 1s, it's scaling fast - yet still under Wall Street's radar.

Iran’s president orders country to suspend cooperation with UN nuclear watchdog IAEA

DUBAI, United Arab Emirates (AP) — Iran’s president on Wednesday ordered the country to suspend its cooperation with after American and Israeli airstrikes hit its most-important nuclear facilities, likely further limiting inspectors' ability to track Tehran's program that had been enriching uranium to near weapons-grade levels.

Mexican banks face cascading consequences following US sanctions

Mexico City (AP) — Three Mexican financial institutions sanctioned by the Trump administration last week have felt a cascade of economic consequences following the allegations that they helped launder millions of dollars for drug cartels.

A Robotics Leader in Disguise - Ad

Forget the hype. Real revenue, growing contracts, and a low float make this stock a hidden gem in the robotics space.

Dubai’s booming restaurant scene is feeling the heat of high costs and high failure rates

DUBAI, United Arab Emirates (AP) — From suspended tables to underwater lounges, some 13,000 food and drink establishments in Dubai pull out all the stops to attract customers in one of the world’s most saturated dining markets.

UnitedHealthcare Group, Gryphon Digital Mining, AMC Entertainment, Centene, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

Major U.S. indices were mixed on Tuesday, with the Dow Jones Industrial Average rising 0.9% to 44,494.94 and the S&P 500 declining 0.1% to 6,198.01. The Nasdaq fell 0.8% to 20,202.89. These are the top stocks that gained the attention of retail traders and investors throughout the day:

FDA Submission Expected This Summer - Invest Before It Happens - Ad

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

Big Banks Pass Fed's 2025 Stress Test With Ease—But Some Say It Was Too Easy

All major U.S. banks passed the Fed's 2025 stress test, but critics say easier assumptions may have padded the results.

AstraZeneca In $15 Billion Talks For Drug That Could Upend Lung Cancer Treatment

AstraZeneca is in advanced talks with Summit Therapeutics over a potential $15 billion deal for the lung cancer drug ivonescimab.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Nike Beats The Street And Says The Worst Is Over

Nike Inc (NKE) stock rallies after upbeat fiscal Q4 results. Analysts maintain Buy ratings, raise price targets, citing potential for growth.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.

US judge says China's Huawei Technologies must face criminal case for racketeering and other charges

BANGKOK (AP) — A U.S. judge has ruled that China’s Huawei Technologies, a leading telecoms equipment company, must face criminal charges in a wide reaching case alleging it stole technology and engaged in racketeering, wire and bank fraud and other crimes.

Ex-Trump Family Attorney Raises Alarms Over Trump's Actions as President: 'I Have Never Been As Concerned'

Abbe Lowell expressed serious concerns about the potential harm that the current administration could cause to the country's institutions.

Robotics Valuation Gap: Who Will Win? - Ad

Two companies. Same sector. Vastly different valuations. One brings in millions in revenue, the other, barely a fraction. The market hasn't caught on yet.

US Credit Card Debt Hits $1.18 Trillion As Americans Downplay What They Owe

American credit card debt has surged to an astronomical $1.18 trillion, with a significant number of individuals reportedly concealing their financial predicaments.

Copper's Spiking - And This Junior Has the Grades to Match - Ad

Copper is climbing again - and this time, it looks tariff-proof. A $31M junior just posted nearly 1B lbs of copper equivalent. With insiders and institutions piling in, this could be the next breakout.

Energy ETFs In Focus After Exxon Flags $1.5 Billion Profit Hit

Exxon's caution pressures energy ETFs like XLE and VDE, as oil prices dip and investors weigh OPEC+ moves and sector rotation risks.

650% Later, Rocket Lab CEO Isn't One Bit Worried

Rocket Lab CEO Peter Beck highlights strong demand for launches from both commercial and government customers.

Elon's Greatest Invention... Hidden in South Memphis? - Ad

In South Memphis, I uncovered what could be Elon Musk's biggest invention yet. It's so secretive, rivals are flying drones to spy on it. If you're serious about investing in AI, now's the time to see what's really going on inside those walls.

Home Depot's $5.5B Deal Expands Its Reach To Thousands Of Job Sites

Analyst maintains Buy rating on Home Depot with $450 price target, noting plans for subsidiary SRS Distribution to acquire GMS for $4.3B.

Gold Just Hit Another Record. This Junior Could Be Next. - Ad

This copper junior was the smallest company invited to a top global mining conference. With nearly 1B pounds CuEq and 50,000m of funded drilling, this story won't stay quiet for long.

GSK Rebranded Flovent Asthma Inhaler For Children To Avoid $367 Million Medicaid Rebate, Senator Hassan Accuses

Senator Maggie Hassan is investigating GSK's discontinuation of Flovent HFA, citing increased hospitalizations, higher drug costs, and lost Medicaid rebates.

Ex-Obama Treasury Secretary Jack Lew Sounds Alarm On NYC Under Zohran Mamdani: 'I Worry Deeply'

With Zohran Mamdani officially securing the Democratic nomination in the New York City mayoral race, centrist figures within the Democratic party, such as former Treasury Secretary Jack Lew, are raising questions on the city's future under a self-described Democratic Socialist.

Robotics Meets Public Safety Innovation - Ad

Advanced security robots, real-world impact, and a valuation gap too big to ignore. This robotics stock is one to watch.

Steve Jobs Took Secrecy To Fight Club Levels For This Critical Mission At Apple — 'People Thought They Knew…But Nobody Knew'

Apple's original iPhone team, under Steve Jobs, operated with intense secrecy, likening their work to "Fight Club," with no one outside the core group knowing the device's design until its 2007 debut.

Once known as 'Dirty Myrtle,' Myrtle Beach is now the fastest-growing US metro for seniors

A South Carolina beach town once nicknamed “Dirty Myrtle” because of its rowdy nightclubs and strip joints has become a magnet for retirees in a nation that continues to age.

From Ferrari to Bombardier - This Tiny Company Is Everywhere - Ad

A $150M disruptor is transforming glass into real-time displays and vision systems. Already embedded in global OEMs and Tier 1s, it's scaling fast - yet still under Wall Street's radar.

Apple Sues Ex-Engineer Over Alleged Theft Of Vision Pro Secrets As Snap Prepares AR Glasses Launch

Apple files lawsuit accusing former senior design engineer of stealing confidential information before leaving to work at Snap.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service